Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Follicular and endocrine dose responses according to anti-Müllerian hormone levels in IVF patients treated with a novel human recombinant FSH (FE 999049).
Bosch E, Nyboe Andersen A, Barri P, García-Velasco JA, de Sutter P, Fernández-Sánchez M, Visnova H, Klein BM, Mannaerts B, Arce JC. Bosch E, et al. Among authors: arce jc. Clin Endocrinol (Oxf). 2015 Dec;83(6):902-12. doi: 10.1111/cen.12864. Epub 2015 Sep 3. Clin Endocrinol (Oxf). 2015. PMID: 26202150 Clinical Trial.
Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection.
Arce JC, Andersen AN, Fernández-Sánchez M, Visnova H, Bosch E, García-Velasco JA, Barri P, de Sutter P, Klein BM, Fauser BC. Arce JC, et al. Fertil Steril. 2014 Dec;102(6):1633-40.e5. doi: 10.1016/j.fertnstert.2014.08.013. Epub 2014 Sep 23. Fertil Steril. 2014. PMID: 25256937 Free article. Clinical Trial.
Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials.
Nelson SM, Klein BM, Arce JC. Nelson SM, et al. Among authors: arce jc. Fertil Steril. 2015 Apr;103(4):923-930.e1. doi: 10.1016/j.fertnstert.2014.12.114. Epub 2015 Jan 24. Fertil Steril. 2015. PMID: 25624196 Free article. Clinical Trial.
Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.
Nyboe Andersen A, Nelson SM, Fauser BC, García-Velasco JA, Klein BM, Arce JC; ESTHER-1 study group. Nyboe Andersen A, et al. Among authors: arce jc. Fertil Steril. 2017 Feb;107(2):387-396.e4. doi: 10.1016/j.fertnstert.2016.10.033. Epub 2016 Nov 29. Fertil Steril. 2017. PMID: 27912901 Free article. Clinical Trial.
Individualization of the starting dose of follitropin delta reduces the overall OHSS risk and/or the need for additional preventive interventions: cumulative data over three stimulation cycles.
Fernández-Sánchez M, Visnova H, Yuzpe A, Klein BM, Mannaerts B, Arce JC; ESTHER-1 and ESTHER-2 Study Group. Fernández-Sánchez M, et al. Among authors: arce jc. Reprod Biomed Online. 2019 Apr;38(4):528-537. doi: 10.1016/j.rbmo.2018.12.032. Epub 2018 Dec 23. Reprod Biomed Online. 2019. PMID: 30713022 Free article. Clinical Trial.
59 results